SRC and systemic sclerosis: This finding is consistent with literature which reports that inhibition of SRC Kinase promotes HCV replication.24 The oncogenic properties of SRC family kinases have been reported with various studies upon role of SRC as target therapy in the treatment of idiopathic pulmonary fibrosis, systemic sclerosis and glioblastoma.